Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LCB01-0371 800mg
DRUG
2 trials
Sponsors
LigaChem Biosciences, Inc.
Conditions
Healthy
Phase 1
Multiple Ascending Dose Study for LCB01-0371
Completed
NCT01842516
LigaChem Biosciences, Inc.
Healthy
Start: 2013-03-31
End: 2013-12-31
Updated: 2014-11-17
Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371
Completed
NCT02540460
LigaChem Biosciences, Inc.
Healthy
Start: 2014-06-30
End: 2015-01-31
Updated: 2015-09-04
Related Papers
Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LCB01-0371 in Healthy Male Volunteers.
2018-11-10
14 citations
Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.
2018-01-01
22 citations